COMBAT-MS
COMBAT-MS is a research project investigating rituximab treatment for MS. We will compare rituximab to all other immunotherapies currently used for MS in a long-term observational study. This study is a collaboration between Kaiser Permanente Southern California (KPSC) and the Karolinska Institutet (KI). It is funded by PCORI for the duration of five years from 2016-2021.
Menu for this area
Results of the research December 2022
The COMBAT-MS project is now finalized and you can read about the results here.